Frankfurt am Main, Germany

Mark Sommerfeld

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Bensheim, DE (2010)
  • Frankfurt-am-Main, DE (2014 - 2024)

Company Filing History:


Years Active: 2010-2024

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: **Mark Sommerfeld: Innovator in Biopharmaceuticals from Frankfurt am Main**

Introduction

Mark Sommerfeld, a prominent inventor based in Frankfurt am Main, Germany, is recognized for his significant contributions to the biopharmaceutical field. With a total of six patents to his name, Sommerfeld has focused his research on innovative approaches to treating various metabolic disorders.

Latest Patents

Among his latest inventions, Sommerfeld has developed groundbreaking technologies including "FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides." This invention presents a new class of proteins with improved physico-chemical properties, which have applications in developing pharmaceutical compositions aimed at enhancing medical treatment options. Another notable patent is related to "FGF21 variants," which discusses polypeptide variants of human fibroblast growth factor 21 and their potential use as medicaments for the treatment of obesity, metabolic syndrome, and related conditions.

Career Highlights

Throughout his career, Mark Sommerfeld has been associated with leading companies such as Sanofi and Sanofi-Aventis Deutschland GmbH. These positions have allowed him to collaborate on cutting-edge biopharmaceutical projects, pushing the boundaries of medical innovation.

Collaborations

Sommerfeld has worked closely with notable colleagues, including Paul Habermann and Norbert Tennagels. Together, they have fostered a creative environment that promotes inventive solutions in the biotechnology sector, facilitating groundbreaking advancements.

Conclusion

Mark Sommerfeld's work exemplifies the spirit of innovation in the biopharmaceutical industry. His patents not only contribute to scientific knowledge but also hold the potential for significant advancements in medical treatments, particularly for metabolic diseases. As he continues to push the envelope of research and development, Sommerfeld remains a pivotal figure in the quest for improved health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…